Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version

Psychotherapy and Psychosomatics

Volumn 78, Issue 2, 2009, Pages 116-124

  Miniati, Mario ^b   Rucci, Paola ^a   Frank, Ellen ^a   Oppo, Annalisa ^b   Kupfer, David J ^a   Fagiolini, Andrea ^a   Cassano, Giovanni B ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Major depression; Mood; Predictive validity; Relapse; Remission; Residual symptoms; Sensitivity to change; Spectrum; Subthreshold

Indexed keywords

CITALOPRAM; ESCITALOPRAM;

ADULT; AGED; ALGORITHM; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MOOD SPECTRUM QUESTIONNAIRE; PHENOTYPE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; QUICK INVENTORY FOR DEPRESSIVE SYMPTOMATOLOGY; RATING SCALE; SELF REPORT; SENSITIVITY ANALYSIS; STRUCTURED INTERVIEW; SYMPTOMATOLOGY;

ADULT; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHOTHERAPY; RECURRENCE; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS;

EID: 59749084310     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000201937     Document Type: Article

References (25)

1. Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004;73:145-148.
2. Fagiolini A, Dell'Osso L, Pini S, Armani A, Endicott J, Maser JD, Rucci P, Grochocinski VJ, Bouanani S, Shear KM, Frank E, Cassano GB: Internal consistency and discriminant validity of a new instrument for assessing mood symptomatology: the structured clinical interview for mood spectrum (SCIMOODS). Int J Methods Psychiatr Res 1999;8:71-82.
3. Dell'Osso L, Armani A, Rucci P, Frank E, Fagiolini A, Corretti G, Shear MK, Grochocinski VJ, Maser JD, Endicott J, Cassano GB: Measuring mood spectrum: comparison of interview (SCI-MOODS) and self-report (MOODS-SR) instruments. Compr Psychiatry 2002;43:69-73.
4. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ: The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry 2004;161:1264-1269.
5. Balestrieri M, Rucci P, Sbrana A, Ravani L, Benvenuti A, Gonnelli C, Dell'Osso L, Cassano GB: Lifetime rhythmicity and mania as correlates of suicidal ideation and attempts in mood disorders. Compr Psychiatry 2006;47:334-341.
6. Piccinni A, Maser JD, Bazzichi L, Rucci P, Vivarelli L, Del Debbio A, Catena M, Bombardieri S, Dell'Osso L: Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis. Compr Psychiatry 2006;47:201-208.
7. Dell'Osso L, Pini S, Maggi L, Rucci P, Del Debbio A, Carlini M, Baldini A, Ferrari G, Manca E, Beverini E: Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders. J Psychosom Res 2007;62:349-355.
8. Wildes JE, Gaskill JA, Ringham R, Marcus MD: Mood spectrum psychopathology in patients with anorexia nervosa. Compr Psychiatry 2007;48:413-418.
9. Klerman GL, Weissmann MM: Interpersonal psychotherapy (IPT) and drugs in the treatment of depression. Pharmacopsychiatry 1987;20:3-7.
10. Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Key T, Biggs MM, Shores-Wilson K, Witte B, Suppes T, Miller AL, Altshuler KZ, Shon SP: Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry 2004;61:669-680.
11. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
12. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-583.
13. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40.
14. Frank E, Prien R, Jarrett RB, Keller MB, Kupfer DJ, Lavori P, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: response, remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-855.
15. Prien RF, Carpenter LL, Kupfer DJ: The definition and operational criteria for treatment outcome of major depressive disorder: a review of the current research literature. Arch Gen Psychiatry 1991;48:796-800.
16. Rush AJ, Schatzberg AF, Gelenber AJ, Regier D, Kupfer DJ, Frank E, Sackeim H, Kraemer HC, Rosenbaum JF, Trivedi MH, Fava M, Michael M, Ray O, Ninan PT: Report by the ACNP Task Force on response and remission to major depressive disorder. Neuropsychopharmacology 2006;31:1841-1853.
17. Blom MB, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, van Dyck R: Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom 2007;76:289-297.
18. Maina G, Rosso G, Crespi C, Bogetto F: Combined Brief Dynamic Therapy and Pharmacotherapy in the Treatment of Major Depressive Disorder: a pilot study. Psychother Psychosom 2007;76:298-305.
19. Bockting CL, Spinhoven P, Koeter MW, Ten Doesschate MC, Spijker J, Schene AH: Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 2008;77:17-26.
20. Keller MB: Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 2003;289:3152-3160.
21. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum Associates, 1988.
22. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A: Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995;25:1171-1180.
23. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB: Major depressive disorder: a prospective study of residual sub-threshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50:97-108.
24. Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB: Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501-1504.
25. Kennedy N, Paykel ES: Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 2004;80:135-144.